Crucell Terug naar discussie overzicht

MOR103 (PerC6 inside) PHASE I

1. flosz 21 september 2012 11:34

   auteur info

   • flosz

     Lid sinds: 13 feb 2008

     Laatste bezoek: 22 jun 2023

   • Aanbevelingen

     Ontvangen: 5298

     Gegeven: 2795

   •    Aantal posts: 7.005

   MorphoSys's MOR103 Antibody Demonstrates Excellent Safety and Efficacy in Rheumatoid Arthritis Patients
   www.morphosys.com/sites/default/files...
   
   MorphoSys to Host Conference Call on Clinical Trial Results of MOR103 in Rheumatoid Arthritis
   09/21/2012 - Conference Call and Webcast: Clinical Trial Results of MOR103 in Rheumatoid Arthritis
   Today at 3:00 p.m. CET (2:00 p.m. BST, 9:00 a.m. EDT), the Management Board of MorphoSys AG will host a public conference call and webcast to present information on the results of the clinical phase 1b/2a trial of MorphoSys's proprietary antibody MOR103 in patients with rheumatoid arthritis, which was announced yesterday.
   www.media-server.com/m/p/wbc89y57